18.50
price up icon6.63%   1.15
after-market After Hours: 18.69 0.19 +1.03%
loading

Adma Biologics Inc Stock (ADMA) Latest News

pulisher
09:30 AM

Adma Biologics (ADMA) Recently Broke Out Above the 50-Day Moving Average - Yahoo Finance

09:30 AM
pulisher
Mar 11, 2025

What's Driving the Market Sentiment Around ADMA Biologics? - Benzinga

Mar 11, 2025
pulisher
Mar 10, 2025

Commit To Buy ADMA Biologics At $10, Earn 14% Using Options - Nasdaq

Mar 10, 2025
pulisher
Mar 10, 2025

Bank of New York Mellon Corp Has $26.09 Million Stock Holdings in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Mar 10, 2025
pulisher
Mar 10, 2025

Mutual of America Capital Management LLC Has $614,000 Stake in ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Mar 10, 2025
pulisher
Mar 09, 2025

Adma Biologics' Retail Traders Eye Higher Open After Blowout Q4, Strong Full-Year Outlook - MSN

Mar 09, 2025
pulisher
Mar 09, 2025

Lost Money on ADMA Biologics, Inc. (ADMA)? Contact Levi & Korsinsky Regarding an Ongoing Investigation - accessnewswire.com

Mar 09, 2025
pulisher
Mar 08, 2025

Lisanti Capital Growth LLC Sells 59,565 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - MarketBeat

Mar 08, 2025
pulisher
Mar 06, 2025

Mizuho lifts ADMA Biologics price target to $32, maintains Outperform - Investing.com

Mar 06, 2025
pulisher
Mar 05, 2025

How Much Upside is Left in Adma Biologics (ADMA)? Wall Street Analysts Think 52.85% - MSN

Mar 05, 2025
pulisher
Mar 05, 2025

ADMA Biologics Stock Climbs Amid Strong Earnings - TipRanks

Mar 05, 2025
pulisher
Mar 05, 2025

ADMA Biologics (NASDAQ:ADMA) Receives “Overweight” Rating from Cantor Fitzgerald - Defense World

Mar 05, 2025
pulisher
Mar 05, 2025

Buy Rating Affirmed for ADMA Biologics Amid Transition to New Auditor and Growth Prospects - TipRanks

Mar 05, 2025
pulisher
Mar 04, 2025

ADMA Biologics Earnings Call Highlights Strong Growth - TipRanks

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc earnings beat by $0.31, revenue topped estimates - Investing.com Australia

Mar 04, 2025
pulisher
Mar 04, 2025

BREAKING: Block & Leviton Investigating ADMA Biologics, - GlobeNewswire

Mar 04, 2025
pulisher
Mar 04, 2025

BREAKING: Block & Leviton Investigating ADMA Biologics, Inc. for Securities Fraud Violations Following Delayed - EIN News

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics slips as 10-K delay overshadows earnings beat - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics stock slips on 10-K delay (ADMA:NASDAQ) - Seeking Alpha

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics, Inc. (NASDAQ:ADMA) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Reports Strong 2024 Financial Performance - MSN

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... - Yahoo Finance

Mar 04, 2025
pulisher
Mar 04, 2025

ADMA Biologics Inc (ADMA) Q4 2024 Earnings Call Highlights: Record Revenue Growth and Strategic ... By GuruFocus - Investing.com Canada

Mar 04, 2025
pulisher
Mar 03, 2025

Earnings call transcript: ADMA Biologics Q4 2024 beats EPS forecast - Investing.com India

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Delays 10-K Filing Amid Auditor Change - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings call transcript: ADMA Biologics Q4 2024 beats EPS forecast By Investing.com - Investing.com Canada

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA BIOLOGICS Earnings Results: $ADMA Reports Quarterly Earnings - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Adma Biologics sees FY26 revenue at least $605M - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Adma Biologics: Q4 Earnings Snapshot - CTPost

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Swings to Q4 Profit, Revenue Increases; Shares Rise After Hours -March 03, 2025 at 04:47 pm EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics stock jumps over 4% on strong Q4 results, raised guidance - Investing.com

Mar 03, 2025
pulisher
Mar 03, 2025

Adma Biologics: Q4 Earnings Snapshot -March 03, 2025 at 04:40 pm EST - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Reports Strong Financial Performance in 2024 - TradingView

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Announces Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update - The Manila Times

Mar 03, 2025
pulisher
Mar 03, 2025

ADMA Biologics Reports 65% Revenue Growth and Significant Increase in Net Income for FY 2024 - Nasdaq

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Flash (ADMA) Adma Biologics Reports Q4 Revenue $117.5M, vs. FactSet Est of $112.8M - Marketscreener.com

Mar 03, 2025
pulisher
Mar 03, 2025

Adma Biologics options imply 11.5% move in share price post-earnings - TipRanks

Mar 03, 2025
pulisher
Mar 03, 2025

Earnings Scheduled For March 3, 2025 - Benzinga

Mar 03, 2025
pulisher
Mar 01, 2025

New York State Common Retirement Fund Sells 11,550 Shares of ADMA Biologics, Inc. (NASDAQ:ADMA) - Defense World

Mar 01, 2025
pulisher
Feb 28, 2025

Shareholder Rights Advocates at Levi & Korsinsky Investigate ADMA Biologics, Inc. (ADMA) Regarding Possible Securities Fraud Violations - ACCESS Newswire

Feb 28, 2025
pulisher
Feb 28, 2025

Okta, Gitlab, ADMA Biologics set to report earnings Friday By Investing.com - Investing.com South Africa

Feb 28, 2025
pulisher
Feb 28, 2025

Okta, Gitlab, ADMA Biologics set to report earnings Friday - Investing.com

Feb 28, 2025
pulisher
Feb 28, 2025

ADMA Biologics Inc (ADMA) Q4 2024: Everything You Need To Know A - GuruFocus.com

Feb 28, 2025
pulisher
Feb 28, 2025

ADMA Biologics Inc (ADMA) Q4 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance

Feb 28, 2025
pulisher
Feb 28, 2025

ADMA Biologics to Participate in the Raymond James Institutional Investor Conference - GlobeNewswire

Feb 28, 2025
$35.01
price up icon 3.70%
$307.09
price up icon 0.88%
$32.85
price up icon 1.20%
$19.91
price up icon 7.62%
$100.31
price up icon 1.95%
biotechnology ONC
$249.84
price up icon 1.68%
Cap:     |  Volume (24h):